Paoletti, M., Marcellusi, A., Yang, J., & Mennini, F. S. (2023). Cost-effectiveness of IMI/CIL/REL for the treatment of carbapenem non-susceptible Gram-negative bacterial infections. Global and Regional Health Technology Assessment, 10(1), 18–28. https://doi.org/10.33393/grhta.2023.2488